SATURDAY (11/4/17)
9:15 am ~ Parking lot opens
9:30 am ~ Doors open
9:30 – 10:00 am ~ Check-in & Coffee
* This conference is sold out. There will be no registration at the door.
10:05 am – 12:30 pm ~ Early Block
Raquel Bennett, Psy.D. – Ketamine Specialist – San Mateo, CA
Overview of Approaches to Working with Ketamine
Steven Levine, M.D. – Psychiatrist – Princeton, NJ
Reflections on 10,000 Administrations of IV Ketamine
Elias Dakwar, M.D. – Psychiatrist – New York, NY
Using Ketamine and Mindfulness Training to Treat People with Substance Use Disorders
12:30 – 1:30 pm ~ Lunch
Drs. Mandel, Levine, Prashad, Bonnett, Hollingsworth, Legarda, Oxley
Q&A Session with American Society of Ketamine Physicians (ASKP)
1:30 – 3:30 pm ~ Middle Block
Gerard Sanacora, M.D. – Psychiatrist – New Haven, CT
Ketamine Studies, Data Collection, and Research Questions
Rupert McShane, M.D. – Psychiatrist – Oxford, England
IV Ketamine for Depression, Daily Mood Monitoring by Patients, and Collecting Aggregate Data from Multiple Providers
Carolyn Rodriguez, M.D. – Psychiatrist – Palo Alto, CA
Ketamine and OCD
3:30 – 4:00 ~ Snack
4:00 – 6:30 pm ~ Late Block
Carl Bonnett, M.D. – Emergency Medicine – San Antonio, TX
IV Ketamine for Veterans with PTSD and Depression
Alison McInnes, M.D. – Psychiatrist – San Francisco, CA
Oral Ketamine and Dextromethorphan
Jason Wallach, Ph.D. – Chemist & Medical Pharmacologist – Philadelphia, PA
Pharmacokinetics & Pharmacodynamics of Ketamine (Absorption, Distribution, Metabolism, Excretion, Potency, Receptor Interactions, etc.)
Drs. Mandel, Oxley, Sullivan
Panel Discussion: Technical Aspects of Working with Ketamine
SUNDAY (11/5/17)
9:15 am ~ Parking lot opens
9:30 am ~ Doors open
9:30 – 10:00 am ~ Check-in & Coffee
10:05 am – 12:30 pm ~ Early Block
Raquel Bennett, Psy.D. – Ketamine Specialist – San Mateo, CA
Current Concerns and Considerations in the Field of Therapeutic Ketamine
Karl Jansen, M.D./Ph.D. – Psychiatrist – Auckland, New Zealand
Is it the Ghost or is it the Machine: How Do We Understand Ketamine’s Antidepressant Effect?
Eli Kolp, M.D. – Psychiatrist – Sarasota, FL
Ketamine-Assisted Psychotherapy and Psychedelic Ketamine
12:30 – 1:30 pm ~ Lunch
Drs. Bennett, Bravo, Jansen, Kolp, Becker, Wolfson
Q&A Session with Psychedelic Psychotherapists
1:30 – 3:30 pm ~ Middle Block
Will Van Derveer, M.D. – Psychiatrist – Boulder, CO
Clinical Case Material
Jeffrey Becker, M.D. – Psychiatrist – Los Angeles, CA
IM Ketamine in Jungian Psychotherapy
Tom Draschil, M.D. – Psychiatrist – Springville, UT
Adding Ketamine Services to a Psychiatry Practice
Wesley Ryan, M.D. – Psychiatrist – Marina Del Rey, CA
Use of Ketamine in a Psychiatry & Addictions Private Practice
3:30 – 4:00 ~ Snack
4:00 – 6:30 pm ~ Late Block
Phil Wolfson, M.D. & Julane Andries, M.F.T. – Psychiatrist & Psychotherapist – San Anselmo, CA
Ketamine-Facilitated Psychotherapy Using Oral & IM Ketamine
Fernando Cantu, M.D. – Anesthesiologist – Monterrey, Mexico
Ketamine Coma for the Treatment of CRPS
Lucinda Grande, M.D. – Family Medicine – Lacy, WA
Oral & Sublingual Ketamine for Patients with Chronic Pain and Depression
Jennifer Winegarden, D.O. – Hospice Physician – Southfield, MI
Ketamine for Pain & Depression in Hospice